<DOC>
	<DOC>NCT01651273</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of BMS-852927 after 28 days of dosing in patients with high cholesterol.</brief_summary>
	<brief_title>A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Men and women, aged ≥18 to ≤75 Body mass index (BMI) ≤ 40 kg/m2 Primary hypercholesterolemia on a stable daily dose of a statin for ≥ 6 weeks Serum triglyceride levels at screening &lt; 400mg/dL (&lt; 4.52 mmol/L) Any significant acute medical illness, significant cardiovascular history Current or history of hepatic or hepatobiliary disease Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations beyond what is consistent with the target population</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>